Related references
Note: Only part of the references are listed.A cathelicidin-related antimicrobial peptide suppresses cardiac hypertrophy induced by pressure overload by regulating IGFR1/PI3K/AKT and TLR9/AMPKα
Xiaofang Wang et al.
CELL DEATH & DISEASE (2020)
Myofibroblast β2 adrenergic signaling amplifies cardiac hypertrophy in mice
Atsuki Imaeda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling
Riikka Kivela et al.
CIRCULATION (2019)
Maresin 1 mitigates renal ischemia/reperfusion injury in mice via inhibition of the TLR4/MAPK/NF-kappa B pathways and activation of the Nrf2 pathway
Yun Qiu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Treatment with maresin 1, a docosahexaenoic acid-derived pro-resolution lipid, protects skin from inflammation and oxidative stress caused by UVB irradiation
Talita L. C. Cezar et al.
SCIENTIFIC REPORTS (2019)
RORα suppresses interleukin-6-mediated hepatic acute phase response
Ju-Yeon Kim et al.
SCIENTIFIC REPORTS (2019)
Inhibition of Smurf2 translation by miR-322/503 protects from ischemia-reperfusion injury by modulating EZH2/Akt/GSK3β signaling
Wei Dong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)
A physiological drop in pH decreases mitochondrial respiration, and HDAC and Akt signaling, in L6 myocytes
Amanda J. Genders et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)
The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure
Ju Youn Beak et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2019)
IL (Interleukin)-10-STAT3-Galectin-3 Axis Is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction
Kohsuke Shirakawa et al.
CIRCULATION (2018)
Unified nexus of macrophages and maresins in cardiac reparative mechanisms
Jeevan Kumar Jadapalli et al.
FASEB JOURNAL (2018)
Mechanisms of physiological and pathological cardiac hypertrophy
Michinari Nakamura et al.
NATURE REVIEWS CARDIOLOGY (2018)
Retinoic Acid Receptor-Related Orphan Receptors: Critical Roles in Tumorigenesis
Jinshuo Fan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Resolution Agonist 15-epi-Lipoxin A4 Programs Early Activation of Resolving Phase in Post-Myocardial Infarction Healing
Vasundhara Kain et al.
SCIENTIFIC REPORTS (2017)
Caveolae-specific activation loop between CaMKII and L-type Ca2+ channel aggravates cardiac hypertrophy in α1-adrenergic stimulation
Kota Tonegawa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
Macrophages in the Remodeling Failing Heart
Bijun Chen et al.
CIRCULATION RESEARCH (2016)
Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice
Joana R. Viola et al.
CIRCULATION RESEARCH (2016)
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Thomas A. Wynn et al.
IMMUNITY (2016)
The nuclear melatonin receptor ROR is a novel endogenous defender against myocardial ischemia/reperfusion injury
Ben He et al.
JOURNAL OF PINEAL RESEARCH (2016)
Macrophage Proresolving Mediators-the When and Where
Jesmond Dalli et al.
MICROBIOLOGY SPECTRUM (2016)
Macrophages are required for neonatal heart regeneration
Arin B. Aurora et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Maresin 1, a Proresolving Lipid Mediator Derived from Omega-3 Polyunsaturated Fatty Acids, Exerts Protective Actions in Murine Models of Colitis
Rodrigo Marcon et al.
JOURNAL OF IMMUNOLOGY (2013)
Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain
Charles N. Serhan et al.
FASEB JOURNAL (2012)
Mechanisms of Resolution of Inflammation A Focus on Cardiovascular Disease
Benjamin H. Maskrey et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Resolvin E1 protects the rat heart against reperfusion injury
K. T. Keyes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Pressure-Mediated Hypertrophy and Mechanical Stretch Induces IL-1 Release and Subsequent IGF-1 Generation to Maintain Compensative Hypertrophy by Affecting Akt and JNK Pathways
Shoken Honsho et al.
CIRCULATION RESEARCH (2009)
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Charles N. Serhan et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Identification of cardiac myocytes as the target of interleukin 11, a cardioprotective cytokine
Ryusuke Kimura et al.
CYTOKINE (2007)
Differences between pathological and physiological cardiac hypertrophy: Novel therapeutic strategies to treat heart failure
Julie R. McMullen et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Regulation of cardiac hypertrophy by intracellular signalling pathways
Joerg Heineke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Hypertrophy of the heart - A new therapeutic target?
N Frey et al.
CIRCULATION (2004)
The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110α) pathway
JR McMullen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy
JR McMullen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
